Maria Carmina Pau

Dr. Maria Carmina Pau


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2026 in Diseases
Verified
Journal Article
Open access
PDF file
MPMaria Carmina Pau
Maria Carmina Pau
EZElisabetta Zinellu
Elisabetta Zinellu
BPBarbara Piras
Barbara Piras
ANAlice Nardi
Alice Nardi
MLMaria Roberta Lacana
Maria Roberta Lacana
PPPietro Pirina
Pietro Pirina
Background: Silicosis is a progressive fibrotic lung disease caused by chronic inhalation of crystalline silica. Increasing evidence indicates that oxidative stress plays a central role in linking silica exposure to inflammation, tissue injury, and fibrosis. We conducted a systematic review to critically appraise the current evidence on the imbalance between oxidant and antioxidant markers in patients with silicosis compared with unexposed healthy controls. Methods: A systematic literature search was conducted in PubMed, Scopus, and Google Scholar from their inception to 30 November 2025. Eligible studies assessed oxidative stress biomarkers in biological samples from patients with silicosis and non-exposed controls. Results: Malondialdehyde (MDA) and Superoxide Dismutase (SOD) were the most frequently assessed oxidative and antioxidant markers, respectively, with MDA significantly increased and SOD decreased in patients with silicosis, highlighting amplified lipid peroxidation and impaired antioxidant defense. In addition, elevated levels of other oxidant molecules confirmed the presence of lipid, nitrosative, and DNA oxidative damage. Overall, antioxidant defenses were compromised, although some markers appeared to vary with disease stage. Conclusions: This review highlights the central role of oxidative stress in the pathogenesis and progression of silicosis. Future studies with larger cohorts and a broader range of biomarkers are needed to better understand oxidative imbalance and its potential utility for monitoring disease progression and assessing severity in this population.

3 August 2024 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
VMValentina Margarita
Valentina Margarita
MPMaria Carmina Pau
Maria Carmina Pau
GCGavino Carboni
Gavino Carboni
FMFranca Mannu
Franca Mannu
FTFrancesco Turrini
Francesco Turrini
PFPier Luigi Fiori
Pier Luigi Fiori